Skip to main content

Table 2 Results review

From: Predicting response to neo-adjuvant chemotherapy and assessment of residual disease in breast cancer using contrast-enhanced spectral mammography: a combined qualitative and quantitative approach

  Number Percentage
Baseline patterns of contrast uptake
 – Solitary Lesion 26/81 32.1
 – Grouped lesion 13/81 16
 – Separated lesion 32/81 39.5
 – Replaced lesion 10/81 12.4
Post-NAC shrinkage patterns
 – Type I (concentric) 24/81 29.6
 – Type II (concentric with surrounding lesions) 15/81 18.5
 – Type III (residual multi-nodular) 9/81 11.1
 – Type IV (diffuse enhancement) 9/81 11.1
 – No residual lesion (complete response) 20/81 24.75
 – No appreciable change (stationary course) 4/81 4.95